全文获取类型
收费全文 | 15316篇 |
免费 | 1092篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 121篇 |
儿科学 | 322篇 |
妇产科学 | 328篇 |
基础医学 | 1866篇 |
口腔科学 | 372篇 |
临床医学 | 1501篇 |
内科学 | 2981篇 |
皮肤病学 | 193篇 |
神经病学 | 1534篇 |
特种医学 | 616篇 |
外科学 | 2421篇 |
综合类 | 179篇 |
现状与发展 | 1篇 |
一般理论 | 28篇 |
预防医学 | 1271篇 |
眼科学 | 508篇 |
药学 | 1184篇 |
中国医学 | 25篇 |
肿瘤学 | 1034篇 |
出版年
2023年 | 129篇 |
2022年 | 95篇 |
2021年 | 557篇 |
2020年 | 308篇 |
2019年 | 463篇 |
2018年 | 544篇 |
2017年 | 398篇 |
2016年 | 410篇 |
2015年 | 506篇 |
2014年 | 681篇 |
2013年 | 802篇 |
2012年 | 1312篇 |
2011年 | 1273篇 |
2010年 | 694篇 |
2009年 | 648篇 |
2008年 | 1014篇 |
2007年 | 1020篇 |
2006年 | 960篇 |
2005年 | 967篇 |
2004年 | 829篇 |
2003年 | 743篇 |
2002年 | 674篇 |
2001年 | 121篇 |
2000年 | 73篇 |
1999年 | 95篇 |
1998年 | 108篇 |
1997年 | 79篇 |
1996年 | 82篇 |
1995年 | 76篇 |
1994年 | 58篇 |
1993年 | 52篇 |
1992年 | 56篇 |
1991年 | 45篇 |
1990年 | 46篇 |
1989年 | 43篇 |
1988年 | 32篇 |
1987年 | 36篇 |
1986年 | 27篇 |
1985年 | 21篇 |
1984年 | 33篇 |
1983年 | 28篇 |
1982年 | 25篇 |
1981年 | 33篇 |
1980年 | 32篇 |
1979年 | 11篇 |
1978年 | 17篇 |
1977年 | 14篇 |
1976年 | 16篇 |
1975年 | 11篇 |
1974年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Journal of Occupational Rehabilitation - The systems that societies construct to support work disability prevention can have powerful effects on both the experiences of people with work disability... 相似文献
2.
3.
4.
Alex John London 《The Hastings Center report》2019,49(1):15-21
Although decision‐making algorithms are not new to medicine, the availability of vast stores of medical data, gains in computing power, and breakthroughs in machine learning are accelerating the pace of their development, expanding the range of questions they can address, and increasing their predictive power. In many cases, however, the most powerful machine learning techniques purchase diagnostic or predictive accuracy at the expense of our ability to access “the knowledge within the machine.” Without an explanation in terms of reasons or a rationale for particular decisions in individual cases, some commentators regard ceding medical decision‐making to black box systems as contravening the profound moral responsibilities of clinicians. I argue, however, that opaque decisions are more common in medicine than critics realize. Moreover, as Aristotle noted over two millennia ago, when our knowledge of causal systems is incomplete and precarious—as it often is in medicine—the ability to explain how results are produced can be less important than the ability to produce such results and empirically verify their accuracy. 相似文献
5.
6.
Masaki Shiota Eiji Kashiwagi Tomohiko Murakami Ario Takeuchi Kenjiro Imada Junichi Inokuchi Katsunori Tatsugami Masatoshi Eto 《Urologic oncology》2019,37(3):180.e19-180.e24
Purpose
Currently, several therapeutic options for castration-resistant prostate cancer (CRPC) are available, for which predictive biomarkers have not been established. Therefore, we aimed to reveal the association between pretreatment serum testosterone level and antitumor outcomes when treated with androgen receptor axis-targeting agents and taxane chemotherapies for CRPC.Patients and methods
The present study included Japanese patients with metastatic prostate cancer whose serum testosterone levels during androgen-deprivation therapy were available. The antitumor outcomes when treated with enzalutamide, abiraterone, docetaxel, and cabazitaxel with clinicopathological parameters including serum testosterone levels during androgen-deprivation therapy, as well as prognoses including progression-free survival and overall survival, were examined.Results
Progression-free survival among men with higher serum testosterone level was superior to that among men with lower serum testosterone level when treated with enzalutamide. On the contrary, progression-free survival and overall survival among men with higher serum testosterone level were significantly inferior to those among men with lower serum testosterone level when treated with docetaxel and cabazitaxel, respectively.Conclusions
The present study indicated distinct prognostic values of serum testosterone level when treated with androgen receptor axis-targeting agent and taxane chemotherapy for CRPC, suggesting that serum testosterone level may be useful predictive biomarker to navigate the appropriate therapy in patients with CRPC. 相似文献7.
8.
9.
10.
Lowenberg David W. DeBaun Malcolm R. Sox-Harris Alex Behn Anthony 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2020,30(2):343-350
European Journal of Orthopaedic Surgery & Traumatology - The indications for the use of intramedullary (IM) nails have been extended to include extra-articular distal metaphyseal tibia... 相似文献